These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1347325)

  • 1. [H2-receptor antagonist-refractory ulcer--its pathophysiology and role of proton-pump inhibitors].
    Arakawa T
    Nihon Rinsho; 1992 Jan; 50(1):122-30. PubMed ID: 1347325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Proton pump inhibitors in the treatment of peptic ulcers resistant to H2-receptor antagonists].
    Asaka M; Kato M; Sato Y; Miyazaki T
    Nihon Rinsho; 1992 Jan; 50(1):104-10. PubMed ID: 1347322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Proton pump inhibitors: their merits and demerits, and perspectives for future investigation].
    Kamada T; Kawano S; Tsuji S
    Nihon Rinsho; 1992 Jan; 50(1):53-9. PubMed ID: 1347330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endoscopic studies on refractory gastric ulcers, especially, linear ulcers, treated with proton pump inhibitor].
    Takase S; Takada A
    Nihon Rinsho; 1992 Jan; 50(1):116-21. PubMed ID: 1347324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment.
    Arakawa T; Higuchi K; Fukuda T; Nakamura H; Kobayashi K
    J Clin Gastroenterol; 1991; 13 Suppl 1():S129-33. PubMed ID: 1682356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Movement of gastric acid secretion and influence of proton pump inhibitors on histamine H2 receptor antagonist resistant ulcer].
    Asaki S; Kimpara T; Ohara S; Hongo M
    Nihon Rinsho; 1992 Jan; 50(1):111-5. PubMed ID: 1347323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine.
    Sakaguchi M; Ashida K; Umegaki E; Miyoshi H; Katsu K
    J Clin Gastroenterol; 1995; 20 Suppl 2():S27-31. PubMed ID: 7594334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Endoscopic ultrasonographic study of gastric ulcer treated with proton pump inhibitor].
    Yoshino J; Nakazawa S; Nakamura T; Yamao K; Inui K; Yamachika H; Watanabe K; Wakabayashi T
    Nihon Rinsho; 1992 Jan; 50(1):81-5. PubMed ID: 1347334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Discovery and development of the proton pump inhibitor].
    Igata H; Okabe S
    Nihon Rinsho; 1992 Jan; 50(1):11-7. PubMed ID: 1311779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effects of gastric proton pump inhibitors on gastric secretion and peptic ulcers].
    Okabe S
    Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):351-60. PubMed ID: 2873085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The therapeutic effect of proton pump inhibitors on Helicobacter pylori-positive gastric ulcers.
    Sasakii M; Joh T; Yokoyama Y; Seno K; Tsuchida K; Kurokawa T; Itoh M
    J Pharm Pharmacol; 1999 Jul; 51(7):825-30. PubMed ID: 10467958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the effect of proton pump inhibitors on stomal ulcer].
    Yukawa K; Yukawa E
    Nihon Rinsho; 1992 Jan; 50(1):138-43. PubMed ID: 1347326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppressive effect of antiulcer agents on granulocytes--a role for granulocytes in gastric ulcer formation.
    Kawamura T; Miyaji C; Toyabe S; Fukuda M; Watanabe H; Abo T
    Dig Dis Sci; 2000 Sep; 45(9):1786-91. PubMed ID: 11052321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Investigation of the therapeutic use of proton pump inhibitor (PPI) by measurement of 24 hour the intra-gastric pH].
    Yamagata S
    Nihon Rinsho; 1992 Jan; 50(1):160-6. PubMed ID: 1347328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lansoprazole. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy in acid-related disorders.
    Spencer CM; Faulds D
    Drugs; 1994 Sep; 48(3):404-30. PubMed ID: 7527761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endoscopic stage classification of peptic ulcer and characterization of the healing process by proton pump inhibitors].
    Karasawa H; Miwa T
    Nihon Rinsho; 1992 Jan; 50(1):74-80. PubMed ID: 1347333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relapse of peptic ulcer after quick healing induced by proton pump inhibitors].
    Tsukamoto Y; Niwa Y; Arisawa T
    Nihon Rinsho; 1992 Jan; 50(1):174-80. PubMed ID: 1371814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison between the ulcer-healing effects of two H(+)-K(+)-ATPase inhibitors, one M1-selective antimuscarinic and one H2 receptor antagonist in the rat.
    Kromer W; Gönne S; Riedel R; Postius S
    Pharmacology; 1990; 41(6):333-7. PubMed ID: 1982899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in the treatment of peptic ulcer following the development of proton pump inhibitors].
    Takemoto T; Inamoto Y
    Nihon Rinsho; 1992 Jan; 50(1):5-10. PubMed ID: 1347329
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.